AQR Capital Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,098
| Closed | -$108K | – | 3301 |
|
|
2025
Q1 | $108K | Sell |
22,098
-4,725
| -18% | -$28.4K | ﹤0.01% | 2999 |
|
|
2024
Q4 | $217K | Sell |
26,823
-7,089
| -21% | -$62K | ﹤0.01% | 2643 |
|
|
2024
Q3 | $352K | Sell |
33,912
-32,814
| -49% | -$546K | ﹤0.01% | 2319 |
|
|
2024
Q2 | $1.22M | Buy |
66,726
+50,657
| +315% | +$1.01M | ﹤0.01% | 1663 |
|
|
2024
Q1 | $411K | Buy |
16,069
+6,680
| +71% | +$171K | ﹤0.01% | 2028 |
|
|
2023
Q4 | $259K | Buy |
9,389
+8,615
| +1,113% | +$525K | ﹤0.01% | 2115 |
|
|
2023
Q3 | $47K | Sell |
774
-3,106
| -80% | -$218K | ﹤0.01% | 2288 |
|
|
2023
Q2 | $255K | Sell |
3,880
-108
| -3% | -$7.9K | ﹤0.01% | 1999 |
|
|
2023
Q1 | $252K | Buy |
3,988
+2,023
| +103% | +$231K | ﹤0.01% | 1991 |
|
|
2022
Q4 | $266K | Sell |
1,965
-837
| -30% | -$118K | ﹤0.01% | 2007 |
|
|
2022
Q3 | $349K | Buy |
+2,802
| New | +$317K | ﹤0.01% | 1900 |
|
|
2021
Q4 | – | Sell |
-4,112
| Closed | -$992K | – | 2205 |
|
|
2021
Q3 | $992K | Buy |
4,112
+2,418
| +143% | +$691K | ﹤0.01% | 1547 |
|
|
2021
Q2 | $665K | Buy |
1,694
+940
| +125% | +$372K | ﹤0.01% | 1780 |
|
|
2021
Q1 | $290K | Buy |
754
+363
| +93% | +$179K | ﹤0.01% | 2019 |
|
|
2020
Q4 | $218K | Buy |
+391
| New | +$248K | ﹤0.01% | 2070 |
|
|
2020
Q3 | – | Sell |
-1,061
| Closed | -$828K | – | 2184 |
|
|
2020
Q2 | $828K | Buy |
+1,061
| New | +$800K | ﹤0.01% | 1542 |
|
|
2018
Q4 | – | Sell |
-915
| Closed | -$1.73M | – | 2191 |
|
|
2018
Q3 | $1.73M | Sell |
915
-2,006
| -69% | -$4.14M | ﹤0.01% | 1463 |
|
|
2018
Q2 | $5.94M | Sell |
2,921
-2,411
| -45% | -$5.5M | 0.01% | 958 |
|
|
2018
Q1 | $11.8M | Buy |
5,332
+590
| +12% | +$1.5M | 0.01% | 727 |
|
|
2017
Q4 | $10.9M | Buy |
4,742
+662
| +16% | +$1.34M | 0.01% | 754 |
|
|
2017
Q3 | $7.26M | Buy |
4,080
+2,149
| +111% | +$3M | 0.01% | 895 |
|
|
2017
Q2 | $2.63M | Buy |
1,931
+492
| +34% | +$594K | ﹤0.01% | 1280 |
|
|
2017
Q1 | $1.7M | Buy |
+1,439
| New | +$1.47M | ﹤0.01% | 1453 |
|
|
2016
Q2 | – | Sell |
-2,907
| Closed | -$1.6M | – | 2200 |
|
|
2016
Q1 | $1.6M | Sell |
2,907
-7,451
| -72% | -$4.58M | ﹤0.01% | 1365 |
|
|
2015
Q4 | $8.62M | Buy |
10,358
+5,963
| +136% | +$5.96M | 0.02% | 759 |
|
|
2015
Q3 | $4.87M | Buy |
4,395
+212
| +5% | +$387K | 0.01% | 820 |
|
|
2015
Q2 | $9.12M | Sell |
4,183
-325
| -7% | -$662K | 0.02% | 639 |
|
|
2015
Q1 | $7.05M | Sell |
4,508
-3,643
| -45% | -$4.81M | 0.02% | 658 |
|
|
2014
Q4 | $9.68M | Buy |
8,151
+6,213
| +321% | +$4.15M | 0.02% | 674 |
|
|
2014
Q3 | $901K | Buy |
+1,938
| New | +$894K | ﹤0.01% | 1665 |
|
Other funds holding BLUE
AQR Capital Management's BLUE Position: Q2 2025 in Review
AQR Capital Management sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 22,098 shares — an estimated $108K sold.
AQR Capital Management first reported a position in BLUE in Q3 2014 and held it in 30 quarters. The position peaked at $11.8M in Q1 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- AQR Capital Management reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- AQR Capital Management sold 22,098 bluebird bio shares in Q2 2025, an estimated $108K.
- AQR Capital Management first reported a position in bluebird bio in Q3 2014 and held it in 30 quarters.
- AQR Capital Management's bluebird bio position peaked at $11.8M in Q1 2018.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on AQR Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.